Press release
Global RNAi Therapeutics Market is Forecast to Reach a Value of USD 20.23 Billion By 2030 with a Growing CAGR of 7.69% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1610
Key Market Insights:
The global RNAi therapeutics market, valued at USD 11.20 billion in 2022, is projected to soar to USD 20.23 billion by 2030, boasting a robust CAGR of 7.69% during the forecast period 2023-2030.
Market Overview:
RNA interference (RNAi) is a biological response to double-stranded RNA, regulating gene expression and resisting both endogenous and exogenous nucleic acids. RNAi therapeutics represent an expanding class of drugs with potential applications across various diseases like oncology, cardiovascular issues, neurodegenerative disorders, and infectious diseases. These therapies target disease-causing genes, once considered undruggable, positioning them as a vital component in the pharmaceutical sector.
Market Drivers:
The burgeoning research and development efforts to address chronic diseases are propelling the RNAi therapeutics market. Rising instances of chronic conditions worldwide, coupled with technological breakthroughs, are driving market expansion. Collaborations between drug distribution companies and Contract Research Organizations (CROs) further contribute to market growth. Despite the complex delivery mechanisms hindering widespread use, advancements in delivery technology are widening clinical applications, especially in oncology and other high-demand areas.
Regional Dynamics:
North America is poised to dominate the RNAi therapeutics market during the forecast period due to escalating pharmaceutical investments and research activities in gene and immunotherapy treatments. The Asia Pacific region shows promising growth with increased healthcare expenditure and the adoption of new technologies. Europe demonstrates substantial demand for RNAi drugs owing to intensive research activities in gene and immunotherapy treatments.
Segmentation Analysis:
The report covers sub-markets based on type (siRNA, miRNA), application (genetic disorders, oncology, neurodegenerative disorders, infectious diseases, renal diseases, and others), route of administration (intradermal, pulmonary, intravenous injections), and end users (diagnostic laboratories, research, and academic laboratories, hospitals).
Company Profiles:
Infinium Global Research profiles market leaders including Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., and others, providing insights into their market strategies and contributions.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/404
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. RNAi Therapeutics Market Highlights
2.2. RNAi Therapeutics Market Projection
2.3. RNAi Therapeutics Market Regional Highlights
Chapter 3. Global RNAi Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by Route of Administration
3.4.4. IGR-Growth Matrix Analysis by End User
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of RNAi Therapeutics Market
Chapter 4. RNAi Therapeutics Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global RNAi Therapeutics Market
5.2. Companies Profiles
5.2.1. Alnylam Pharmaceuticals, Inc.
5.2.2. QIAGEN
5.2.3. Olix Pharmaceuticals, Inc.
5.2.4. Arbutus Biopharma
5.2.5. Silence Therapeutics
5.2.6. Dicerna Pharmaceuticals, Inc
5.2.7. Arrowhead Pharmaceuticals, Inc.
5.2.8. Quark Software Inc.
5.2.9. Phio Pharmaceuticals
5.2.10. Benitec Biopharma Ltd
Chapter 6. Global RNAi Therapeutics Market by Type
6.1. Small interfering RNA (siRNA)
6.2. MicroRNA (miRNA)
Chapter 7. Global RNAi Therapeutics Market by Application
7.1. Genetic Disorders
7.2. Oncology
7.3. Neurodegenerative Disorders
7.4. Infectious Diseases
7.5. Renal Diseases
7.6. Others
Chapter 8. Global RNAi Therapeutics Market by Route of Administration
8.1. Intradermal Injections
8.2. Pulmonary Delivery
8.3. Intravenous Injections
Chapter 9. Global RNAi Therapeutics Market by End User
9.1. Diagnostic Laboratories
9.2. Research and Academic Laboratories
9.3. Hospitals
Chapter 10. Global RNAi Therapeutics Market by Region 2023-2030
10.1. North America
10.1.1. North America RNAi Therapeutics Market by Type
10.1.2. North America RNAi Therapeutics Market by Application
10.1.3. North America RNAi Therapeutics Market by Route of Administration
10.1.4. North America RNAi Therapeutics Market by End User
10.1.5. North America RNAi Therapeutics Market by Country
10.1.5.1. The U.S. RNAi Therapeutics Market
10.1.5.1.1. The U.S. RNAi Therapeutics Market by Type
10.1.5.1.2. The U.S. RNAi Therapeutics Market by Application
10.1.5.1.3. The U.S. RNAi Therapeutics Market by Route of Administration
10.1.5.1.4. The U.S. RNAi Therapeutics Market by End User
10.1.5.2. Canada RNAi Therapeutics Market
10.1.5.2.1. Canada RNAi Therapeutics Market by Type
10.1.5.2.2. Canada RNAi Therapeutics Market by Application
10.1.5.2.3. Canada RNAi Therapeutics Market by Route of Administration
10.1.5.2.4. Canada RNAi Therapeutics Market by End User
10.1.5.3. Mexico RNAi Therapeutics Market
10.1.5.3.1. Mexico RNAi Therapeutics Market by Type
10.1.5.3.2. Mexico RNAi Therapeutics Market by Application
10.1.5.3.3. Mexico RNAi Therapeutics Market by Route of Administration
10.1.5.3.4. Mexico RNAi Therapeutics Market by End User
10.2. Europe
10.2.1. Europe RNAi Therapeutics Market by Type
10.2.2. Europe RNAi Therapeutics Market by Application
10.2.3. Europe RNAi Therapeutics Market by Route of Administration
10.2.4. Europe RNAi Therapeutics Market by End User
10.2.5. Europe RNAi Therapeutics Market by Country
10.2.5.1. Germany RNAi Therapeutics Market
10.2.5.1.1. Germany RNAi Therapeutics Market by Type
10.2.5.1.2. Germany RNAi Therapeutics Market by Application
10.2.5.1.3. Germany RNAi Therapeutics Market by Route of Administration
10.2.5.1.4. Germany RNAi Therapeutics Market by End User
10.2.5.2. United Kingdom RNAi Therapeutics Market
10.2.5.2.1. United Kingdom RNAi Therapeutics Market by Type
10.2.5.2.2. United Kingdom RNAi Therapeutics Market by Application
10.2.5.2.3. United Kingdom RNAi Therapeutics Market by Route of Administration
10.2.5.2.4. United Kingdom RNAi Therapeutics Market by End User
10.2.5.3. France RNAi Therapeutics Market
10.2.5.3.1. France RNAi Therapeutics Market by Type
10.2.5.3.2. France RNAi Therapeutics Market by Application
10.2.5.3.3. France RNAi Therapeutics Market by Route of Administration
10.2.5.3.4. France RNAi Therapeutics Market by End User
10.2.5.4. Italy RNAi Therapeutics Market
10.2.5.4.1. Italy RNAi Therapeutics Market by Type
10.2.5.4.2. Italy RNAi Therapeutics Market by Application
10.2.5.4.3. Italy RNAi Therapeutics Market by Route of Administration
10.2.5.4.4. Italy RNAi Therapeutics Market by End User
10.2.5.5. Rest of Europe RNAi Therapeutics Market
10.2.5.5.1. Rest of Europe RNAi Therapeutics Market by Type
10.2.5.5.2. Rest of Europe RNAi Therapeutics Market by Application
10.2.5.5.3. Rest of Europe RNAi Therapeutics Market by Route of Administration
10.2.5.5.4. Rest of Europe RNAi Therapeutics Market by End User
10.3. Asia Pacific
10.3.1. Asia Pacific RNAi Therapeutics Market by Type
10.3.2. Asia Pacific RNAi Therapeutics Market by Application
10.3.3. Asia Pacific RNAi Therapeutics Market by Route of Administration
10.3.4. Asia Pacific RNAi Therapeutics Market by End User
10.3.5. Asia Pacific RNAi Therapeutics Market by Country
10.3.5.1. China RNAi Therapeutics Market
10.3.5.1.1. China RNAi Therapeutics Market by Type
10.3.5.1.2. China RNAi Therapeutics Market by Application
10.3.5.1.3. China RNAi Therapeutics Market by Route of Administration
10.3.5.1.4. China RNAi Therapeutics Market by End User
10.3.5.2. Japan RNAi Therapeutics Market
10.3.5.2.1. Japan RNAi Therapeutics Market by Type
10.3.5.2.2. Japan RNAi Therapeutics Market by Application
10.3.5.2.3. Japan RNAi Therapeutics Market by Route of Administration
10.3.5.2.4. Japan RNAi Therapeutics Market by End User
10.3.5.3. India RNAi Therapeutics Market
10.3.5.3.1. India RNAi Therapeutics Market by Type
10.3.5.3.2. India RNAi Therapeutics Market by Application
10.3.5.3.3. India RNAi Therapeutics Market by Route of Administration
10.3.5.3.4. India RNAi Therapeutics Market by End User
10.3.5.4. South Korea RNAi Therapeutics Market
10.3.5.4.1. South Korea RNAi Therapeutics Market by Type
10.3.5.4.2. South Korea RNAi Therapeutics Market by Application
10.3.5.4.3. South Korea RNAi Therapeutics Market by Route of Administration
10.3.5.4.4. South Korea RNAi Therapeutics Market by End User
10.3.5.5. Australia RNAi Therapeutics Market
10.3.5.5.1. Australia RNAi Therapeutics Market by Type
10.3.5.5.2. Australia RNAi Therapeutics Market by Application
10.3.5.5.3. Australia RNAi Therapeutics Market by Route of Administration
10.3.5.5.4. Australia RNAi Therapeutics Market by End User
10.3.5.6. Rest of Asia-Pacific RNAi Therapeutics Market
10.3.5.6.1. Rest of Asia-Pacific RNAi Therapeutics Market by Type
10.3.5.6.2. Rest of Asia-Pacific RNAi Therapeutics Market by Application
10.3.5.6.3. Rest of Asia-Pacific RNAi Therapeutics Market by Route of Administration
10.3.5.6.4. Rest of Asia-Pacific RNAi Therapeutics Market by End User
10.4. RoW
10.4.1. RoW RNAi Therapeutics Market by Type
10.4.2. RoW RNAi Therapeutics Market by Application
10.4.3. RoW RNAi Therapeutics Market by Route of Administration
10.4.4. RoW RNAi Therapeutics Market by End User
10.4.5. RoW RNAi Therapeutics Market by Sub-region
10.4.5.1. Latin America RNAi Therapeutics Market
10.4.5.1.1. Latin America RNAi Therapeutics Market by Type
10.4.5.1.2. Latin America RNAi Therapeutics Market by Application
10.4.5.1.3. Latin America RNAi Therapeutics Market by Route of Administration
10.4.5.1.4. Latin America RNAi Therapeutics Market by End User
10.4.5.2. Middle East RNAi Therapeutics Market
10.4.5.2.1. Middle East RNAi Therapeutics Market by Type
10.4.5.2.2. Middle East RNAi Therapeutics Market by Application
10.4.5.2.3. Middle East RNAi Therapeutics Market by Route of Administration
10.4.5.2.4. Middle East RNAi Therapeutics Market by End User
10.4.5.3. Africa RNAi Therapeutics Market
10.4.5.3.1. Africa RNAi Therapeutics Market by Type
10.4.5.3.2. Africa RNAi Therapeutics Market by Application
10.4.5.3.3. Africa RNAi Therapeutics Market by Route of Administration
10.4.5.3.4. Africa RNAi Therapeutics Market by End User
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/404
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of RNAi therapeutics.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global RNAi Therapeutics Market is Forecast to Reach a Value of USD 20.23 Billion By 2030 with a Growing CAGR of 7.69% | Infinium Global Research here
News-ID: 3317949 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
